General objective
The project aims to develop an innovative three-dimensional model based on patient-derived cells for amyotrophic lateral sclerosis (ALS), using stem cells obtained from urine. This model will enable advances in understanding this rare, progressive disease, improve knowledge of its pathophysiology, and facilitate the development of more precise and effective therapies. Led by a cross-border consortium, the project also seeks to strengthen research, innovation, and technology transfer capabilities in the region, fostering significant improvements in the quality of research and available treatments for patients.
Specific objectives
Creation of an innovative 3D model to advance ALS research
Strengthening collaboration between Spain and Portugal
Application of advanced technologies to study ALS
Raising awareness about ALS
